Pediatrix Medical Group 超出了第三季度的收益预测，尽管评级为“持有”，但其股价仍上涨至 16.25 美元。 Pediatrix Medical Group exceeded Q3 earnings forecasts, boosting its stock to $16.25 despite a "Hold" rating.

Pediatrix医疗组报告,从分析师预测的0.37美元中,每股0.49美元的Q3收入高于预期。 Pediatrix Medical Group reported a higher-than-expected Q3 earnings of $0.49 per share, up from analyst forecasts of $0.37. 公司股价上升,平均达到16.25美元,评级为“稳住”。 The company's stock saw a boost, reaching $16.25 on average, with a "Hold" rating. Pediatrix在美国各地提供新生儿和儿科专科护理服务。 几位分析家提高了价格目标,尽管机构投资者持有存量的97.71%。 Pediatrix provides newborn and pediatric specialty care services across the U.S. Several analysts raised their price targets, though institutional investors hold 97.71% of the stock.